Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes

被引:10
作者
Baumann, Carmen [1 ]
Sabatino, Francesco [2 ]
Zheng, Yalin [3 ]
Johannigmann-Malek, Navid [1 ]
Maier, Mathias [1 ]
Kaye, Stephen B. [3 ]
Patton, Niall [2 ]
机构
[1] Tech Univ Munich TUM, Hosp Rechts Isar, Dept Ophthalmol, Ismaninger Str 22, D-81675 Munich, Germany
[2] Manchester Royal Eye Hosp, Oxford Rd, Manchester M13 9WL, Lancs, England
[3] Univ Liverpool, William Henry Duncan Bldg,6 West Derby St, Liverpool L7 8TX, Merseyside, England
关键词
Pneumatic vitreolysis; Vitreomacular traction; Macular hole; OPTICAL COHERENCE TOMOGRAPHY; INTRAVITREAL OCRIPLASMIN; PERFLUOROPROPANE C3F8; GAS; INJECTION;
D O I
10.1007/s00417-022-05568-y
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To evaluate the outcome of pneumatic vitreolysis (PVL) for vitreomacular traction (VMT) with or without full thickness macular hole (MH) < 400 mu m. Methods Forty-seven eyes of 47 patients were included who had undergone PVL for VMT with or without MH. Main outcome measures were release of VMT, MH closure, best-corrected visual acuity (BCVA) and adverse events. Results Thirty-three patients had isolated VMT and 14 patients VMT with a MH. Four weeks after PVL, the overall VMT release rate was 35/47 (74.5%): 25/37 (67.6%) in phakic and 10/10 (100%) in pseudophakic eyes (p = 0.03). Four of 14 MH (28.6%) were closed. Twenty-two of 47 (46.8%) eyes required a subsequent PPV: 12/33 (36.4%) in the VMT only group and 10/14 (71.4%) in the VMT with MH group. Mean BCVA improved from 0.48 (+/- 0.24) to 0.34 (+/- 0.23) logMAR at 6 months in patients with VMT alone (p < 0.001), and from 0.57 (+/- 0.27) to 0.41 (+/- 0.28) logMAR in patients with VMT and MH (p = 0.008). Adverse events included new formation of a large MH in 4/33 (12.1%) eyes, failure of MH closure in 10/14 (71.4%) eyes, progression of mean minimum linear diameter (MLD) MH size from baseline 139 (+/- 67) to 396 (+/- 130) mu m (p < 0.001) and development of a retinal detachment in 4/47 (8.5%) eyes. Conclusion While PVL leads to a high VMT release rate particularly in pseudophakic eyes, it is associated with a relatively high incidence of MH formation, MH size progression and retinal detachment.
引用
收藏
页码:2209 / 2215
页数:7
相关论文
共 28 条
[1]   Intravitreal gas injection for the treatment of full-thickness macular holes [J].
Anderson, Matthew Frederick ;
Magal, Itay ;
Ells, Anna ;
Fielden, Michael ;
Mahsin, Md ;
Kherani, Amin ;
Williams, R. Geoff .
CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2020, 55 (01) :E13-E18
[2]   FUNCTIONAL AND MORPHOLOGICAL OUTCOMES OF THE INVERTED INTERNAL LIMITING MEMBRANE FLAP TECHNIQUE IN SMALL-SIZED AND MEDIUM-SIZED MACULAR HOLES &lt;400 μm [J].
Baumann, Carmen ;
Dervenis, Nikolaos ;
Kirchmair, Katharina ;
Lohmann, Chris P. ;
Kaye, Stephen B. ;
Sandinha, Maria T. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2021, 41 (10) :2073-2078
[3]   TREATMENT OF IDIOPATHIC MACULAR HOLES BY INDUCED POSTERIOR VITREOUS DETACHMENT [J].
CHAN, CK ;
WESSELS, IF ;
FRIEDRICHSEN, EJ .
OPHTHALMOLOGY, 1995, 102 (05) :757-767
[4]   Pneumatic Vitreolysis with Perfluoropropane for Vitreomacular Traction with and without Macular Hole DRCR Retina Network Protocols AG and AH [J].
Chan, Clement K. ;
Mein, Calvin E. ;
Glassman, Adam R. ;
Beaulieu, Wesley T. ;
Calhoun, Claire T. ;
Jaffe, Glenn J. ;
Jampol, Lee M. ;
MacCumber, Mathew W. ;
Maguire, Maureen G. ;
Maturi, Raj K. ;
Salehi-Had, Hani ;
Rofagha, Soraya ;
Sun, Jennifer K. ;
Martin, Daniel F. .
OPHTHALMOLOGY, 2021, 128 (11) :1592-1603
[5]   PNEUMATIC VITREOLYSIS FOR RELIEF OF VITREOMACULAR TRACTION [J].
Chan, Clement K. ;
Crosson, Jason N. ;
Mein, Calvin E. ;
Daher, Noha .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (10) :1820-1831
[6]   Optical coherence tomography evaluation of idiopathic macular hole treatment by gas-assisted posterior vitreous detachment [J].
Costa, RA ;
Cardillo, JA ;
Morales, PH ;
Jorge, R ;
Uno, F ;
Farah, ME .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (02) :264-266
[7]   Microplasmin Intravitreal Administration in Patients with Vitreomacular Traction Scheduled for Vitrectomy The MIVI I Trial [J].
de Smet, Marc D. ;
Gandorfer, Arnd ;
Stalmans, Peter ;
Veckeneer, Marc ;
Feron, Eric ;
Pakola, Steve ;
Kampik, Anselm .
OPHTHALMOLOGY, 2009, 116 (07) :1349-1355
[8]   Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial [J].
Dugel, Pravin U. ;
Tolentino, Michael ;
Feiner, Leonard ;
Kozma, Petra ;
Leroy, Annick .
OPHTHALMOLOGY, 2016, 123 (10) :2232-2247
[9]   Acute Panretinal Structural and Functional Abnormalities After Intravitreous Ocriplasmin Injection [J].
Fahim, Abigail T. ;
Khan, Naheed W. ;
Johnson, Mark W. .
JAMA OPHTHALMOLOGY, 2014, 132 (04) :484-486
[10]   Posterior vitreous detachment induced by microplasmin [J].
Gandorfer, A ;
Rohleder, M ;
Sethi, C ;
Eckle, D ;
Welge-Hüssen, U ;
Kampik, A ;
Lutbert, P ;
Charteris, D .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 (02) :641-647